Login / Signup

Chart review across EU5 in MM post-ASCT patients.

John AshcroftDavneet JudgeSujith DhanasiriGavin Taylor-StokesChloe Middleton
Published in: International journal of hematologic oncology (2018)
The study highlights the diversity in current treatment patterns post-ASCT. Results suggest patients who receive maintenance therapy have a prolonged remission period, and as a result their associated healthcare resource utilization is spread across the treatment pathway.
Keyphrases
  • healthcare
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • ejection fraction
  • combination therapy
  • stem cells
  • mesenchymal stem cells
  • bone marrow
  • cell therapy
  • health information
  • ulcerative colitis